Gemmus Pharma
Pioneering new horizons in influenza treatment with innovative cardiovascular solutions.
General Information
BounceWatch is an independent company data service, not affiliated with Gemmus Pharma. To contact Gemmus Pharma, visit gemmuspharma.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Gemmus Pharma compare?
A PDF of Gemmus Pharma and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Gemmus Pharma soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
Discover More
About Gemmus Pharma
Business keywords: Pharmaceuticals, Drug Development, Cardiovascular Solutions, Innovative Treatment, Influenza, Series A Funding, FDA Regulation, Investigational New Drug Application, National Institute of Allergy and Infectious Disease, Asia Market, License Technology, Startup, Investment
Funding Rounds & Investors (2)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Series B | $3.30M | 5 |
|
13 May 2014 |
| Series A | $1.80M | 5 |
|
28 Jun 2012 |
Gemmus Pharma Alternatives & Competitors
View All Alternatives
Pioneering innovative therapies for life-threatening conditions, aiming to enhance anemia treatment...
We’re changing the way the world treats inflammation and the way the pharma industry treats humanity
Pioneering pain management with innovative products and advanced abuse prevention technologies
FAQ About Gemmus Pharma
Source: BounceWatch company record for Gemmus Pharma, https://bouncewatch.com/company/gemmus-pharma, updated 10 October 2024. When citing, please name BounceWatch and link this page.
